Atsushi Okano Selected Research

Atsushi Okano Research Topics

3	Meningioma (Meningiomas) 06/2022 - 01/2022
2	Neoplasms (Cancer) 08/2014 - 04/2014
1	Vascular Diseases (Vascular Disease) 06/2022
1	Granuloma 01/2022
1	Chordoma 01/2022
1	Chondrosarcoma 01/2022
1	Neurilemmoma (Schwannoma) 01/2022
1	Osteoblastoma 01/2022
1	Epidermal Cyst (Sebaceous Cyst) 01/2022
1	Myelitis 12/2021
1	Lymphoma (Lymphomas) 12/2021
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 10/2021
1	Hydrocephalus (Hydrocephaly) 12/2018
1	Plasma Cell Granuloma 06/2015
1	Autoimmune Pancreatitis 06/2015
1	Aspergillosis 01/2015
1	Teratoma (Teratoid Tumor) 08/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2014
1	Infarction (Infarctions) 04/2014
1	Hypertension (High Blood Pressure) 04/2014
1	Craniocerebral Trauma (Head Injury) 04/2014
1	Diabetes Mellitus 04/2014
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2013

2	SteroidsIBA 12/2021 - 06/2015
1	Biological ProductsIBA 06/2022
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	Forkhead Box Protein M1IBA 01/2022
1	CholesterolIBA 01/2022
1	GadoliniumIBA 12/2021
1	Interleukin-10 (Interleukin 10)IBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2021
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 12/2018
1	Immunoglobulin G (IgG)IBA 06/2015
1	Antifungal AgentsIBA 01/2015
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2014
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 04/2014
1	AnticoagulantsIBA 04/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2014
1	fasudil (AT 877)IBA 01/2013